Matthews Pacific Tiger Active ETF(ASIA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASIA Matthews Pacific Tiger Active ETF

休市中 12-19 16:00:00 EST

33.42

+0.39

+1.18%

盘后33.56

+0.15+0.43%

16:10 EST

最高33.56	最低33.42	成交量331.00
今开33.56	昨收33.03	日振幅0.44%
总市值4,177万	流通市值4,177万	总股本125.00万
成交额1.11万	换手率0.03%	流通股本125.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASIA","market":"US","secType":"STK","nameCN":"Matthews Pacific Tiger Active ETF","latestPrice":33.415,"timestamp":1766178000000,"preClose":33.0251,"halted":0,"volume":331,"hourTrading":{"tag":"盘后","latestPrice":33.56,"preClose":33.415,"latestTime":"16:10 EST","volume":6,"amount":200.49,"timestamp":1766178603955},"delay":0,"floatShares":1250000,"shares":1250000,"eps":0,"marketStatus":"休市中","change":0.3899,"latestTime":"12-19 16:00:00 EST","open":33.56,"high":33.56,"low":33.415,"amount":11073.94924,"amplitude":0.004391,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":33.0251,"sharesOutstanding":1250000,"nav":32.79,"aum":40987552.11,"dividendRate":0.010675,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.56,"preClose":33.415,"latestTime":"16:10 EST","volume":6,"amount":200.49,"timestamp":1766178603955},"volumeRatio":0.10632147123630312},"requestUrl":"/m/hq/s/ASIA","defaultTab":"news","newsList":[{"id":"2586472286","title":"港股异动 | 复宏汉霖(02696)涨超5% 多元实体瘤管线将亮相ESMO ASIA 2025大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2586472286","media":"智通财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586472286?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:56","pubTimestamp":1764122170,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖涨超5%，截至发稿，涨4.7%，报70.15港元，成交额1635万港元。消息面上，据复宏汉霖官微消息，ESMO ASIA 2025将于12月5日~12月7日在新加坡召开。其中，广谱抗肿瘤ADC HLX43在宫颈癌领域的II期临床数据将在大会上首次发布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02696","HK0000165453.HKD","ASIA"],"gpt_icon":0},{"id":"2586461429","title":"ASIA COMM HOLD(00104)发布中期业绩 股东应占溢利3280.4万港元 同比减少8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586461429","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586461429?lang=zh_cn&edition=full","pubTime":"2025-11-25 18:10","pubTimestamp":1764065423,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ASIA COMM HOLD(00104)发布截至2025年9月30日止6个月业绩，该集团期内取得营业收入3.09亿港元，同比减少9%;归属于公司持有人的溢利3280.4万港元，同比减少8%;每股基本盈利4.39港仙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373383.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HOLD","BK4020","ASIA","BK1224","COMM","00104"],"gpt_icon":0},{"id":"2563858857","title":"高地股份(01676)：终止收购ABLE TALENT ASIA LIMITED","url":"https://stock-news.laohu8.com/highlight/detail?id=2563858857","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563858857?lang=zh_cn&edition=full","pubTime":"2025-08-31 18:13","pubTimestamp":1756635228,"startTime":"0","endTime":"0","summary":"智通财经APP讯，高地股份(01676)发布公告，由于公司尚未满意公司对目标集团进行之尽职审查所得出之结果，收购协议项下之先决条件并未于2025年8月31日前全部达成。因此，收购协议已于2025年8月31日失效，收购协议亦随即终止，公司及卖方同意即时终止及解除彼此于收购协议项下各自之责任。于本公告日，集团尚未支付首期付款或任何其他代价。公司认为终止收购协议对集团整体业务营运并无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1339499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01676","ASIA","ABLE","BK4144","BK1237"],"gpt_icon":0},{"id":"2514096376","title":"【宏柏新材：与迈图投资有限公司等签订合资经营合同】 宏柏新材2月25日晚间公告，公司董事会审议通过《关于公司与迈图投资有限公司、MOMENTIVEPERFORMANCE MATERIALS ASIA PACIFIC PTE.LTD.签订合资经营合同的议案》，合资公司中文名称为“迈图宏柏高新材料有限公司”，注册资本暂定为人民币7.2亿元或等值美元，其中公司拟以非货币资产认缴出资暂定为人民币3.672亿元或等值美元，占合资公司注册资本的51%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096376","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514096376?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:41","pubTimestamp":1740487269,"startTime":"0","endTime":"0","summary":"宏柏新材2月25日晚间公告，公司董事会审议通过《关于公司与迈图投资有限公司、MOMENTIVEPERFORMANCE MATERIALS ASIA PACIFIC PTE.LTD.签订合资经营合同的议案》，合资公司中文名称为“迈图宏柏高新材料有限公司”，注册资本暂定为人民币7.2亿元或等值美元，其中公司拟以非货币资产认缴出资暂定为人民币3.672亿元或等值美元，占合资公司注册资本的51%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25204148382140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARKG","BK4544","BK4588","BK0229","159703","605366","BK4585","ASIA"],"gpt_icon":0},{"id":"2490932990","title":"友芝友生物-B(02496)：M701恶性腹水II期研究更新数据在2024年ESMO-ASIA会议上公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2490932990","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490932990?lang=zh_cn&edition=full","pubTime":"2024-12-10 18:52","pubTimestamp":1733827976,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 发布公告，公司自主研发的上皮细胞黏附分子和分化簇3双靶向的在研双特异性抗体药物 M701在中国开展的治疗晚期上皮实体瘤引发的恶性腹水的II期临床研究的研究更新数据已以大会口头报告的形式在2024年欧洲肿瘤内科学会亚洲分会上公布。后续每2周腹腔灌注1次M701，且不再引流腹水。两组受试者均同时接受研究者指定的全身系统性治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ASIA","BK1161","02496"],"gpt_icon":0},{"id":"2486384919","title":"ASIA COMM HOLD(00104)发布中期业绩，股东应占溢利3581.6万港元 同比增加16.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486384919","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486384919?lang=zh_cn&edition=full","pubTime":"2024-11-27 18:26","pubTimestamp":1732703203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ASIA COMM HOLD(00104)发布截至2024年9月30日止6个月业绩，该集团取得营业收入3.38亿港元，同比持平;公司持有人应占溢利3581.6万港元，同比增加16.61%;每股盈利4.79港仙。截至2024年9月30日止6个月，集团的营业收入为3.38亿港元，与去年相同，主要由于来自中国的销售额于两个期间保持稳定所致(2023年：增加16%)。于本期间，中国香港及中国内地的销售分别为500万港元及3.33亿港元，较去年同期分别减少11%及轻微增加0.2%。本期间的毛利率为32%，与去年的33%相若。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4020","00104","COMM","HOLD","ASIA","BK1224"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.matthewsasia.com/funds/etfs/pacific-tiger-active-etf/","stockEarnings":[{"period":"1week","weight":0.0016},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0103},{"period":"6month","weight":0.1915},{"period":"1year","weight":0.2593},{"period":"ytd","weight":0.2773}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"AMEX","name":"Matthews Pacific Tiger Active ETF","nameEN":"Matthews Pacific Tiger Active ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Matthews Pacific Tiger Active ETF(ASIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Matthews Pacific Tiger Active ETF(ASIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Matthews Pacific Tiger Active ETF,ASIA,Matthews Pacific Tiger Active ETF股票,Matthews Pacific Tiger Active ETF股票老虎,Matthews Pacific Tiger Active ETF股票老虎国际,Matthews Pacific Tiger Active ETF行情,Matthews Pacific Tiger Active ETF股票行情,Matthews Pacific Tiger Active ETF股价,Matthews Pacific Tiger Active ETF股市,Matthews Pacific Tiger Active ETF股票价格,Matthews Pacific Tiger Active ETF股票交易,Matthews Pacific Tiger Active ETF股票购买,Matthews Pacific Tiger Active ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Matthews Pacific Tiger Active ETF(ASIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Matthews Pacific Tiger Active ETF(ASIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}